Chembond Material Technologies Ltd
Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]
- Market Cap ₹ 239 Cr.
- Current Price ₹ 178
- High / Low ₹ 309 / 105
- Stock P/E 28.2
- Book Value ₹ 127
- Dividend Yield 0.98 %
- ROCE 6.89 %
- ROE 5.08 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
Cons
- Company has a low return on equity of 6.39% over last 3 years.
- Working capital days have increased from 69.5 days to 101 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 217 | 216 | 218 | 232 | 156 | 58 | 42 | 46 | 51 | 153 | 171 | 210 | |
| 209 | 217 | 215 | 225 | 151 | 57 | 38 | 42 | 49 | 145 | 158 | 198 | |
| Operating Profit | 8 | -1 | 4 | 7 | 5 | 2 | 4 | 4 | 2 | 9 | 13 | 12 |
| OPM % | 4% | -0% | 2% | 3% | 3% | 3% | 9% | 8% | 3% | 6% | 8% | 6% |
| 3 | 190 | 17 | 10 | 6 | 7 | 12 | 10 | 5 | 14 | 9 | 1 | |
| Interest | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 |
| Profit before tax | 6 | 186 | 17 | 14 | 7 | 5 | 13 | 11 | 5 | 19 | 19 | 10 |
| Tax % | 3% | 19% | 16% | 3% | 10% | -5% | 24% | 20% | 13% | 29% | 10% | 24% |
| 6 | 151 | 15 | 14 | 6 | 6 | 10 | 9 | 4 | 14 | 17 | 8 | |
| EPS in Rs | 4.16 | 112.86 | 10.84 | 10.14 | 4.72 | 4.13 | 7.22 | 6.52 | 2.96 | 10.31 | 12.85 | 5.79 |
| Dividend Payout % | 36% | 4% | 15% | 18% | 42% | 49% | 31% | 77% | 102% | 34% | 14% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 38% |
| 3 Years: | 61% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -3% |
| 3 Years: | 44% |
| TTM: | -45% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 3% |
| 3 Years: | -10% |
| 1 Year: | -40% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 4% |
| 3 Years: | 6% |
| Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 46 | 190 | 208 | 219 | 223 | 223 | 233 | 238 | 235 | 145 | 157 | 163 |
| 22 | 8 | 7 | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |
| 49 | 46 | 52 | 50 | 21 | 10 | 12 | 10 | 12 | 37 | 38 | 42 | |
| Total Liabilities | 123 | 251 | 274 | 280 | 250 | 240 | 251 | 255 | 254 | 189 | 202 | 212 |
| 36 | 37 | 38 | 37 | 36 | 36 | 34 | 32 | 28 | 26 | 33 | 40 | |
| CWIP | 2 | 2 | 2 | 1 | 2 | 0 | 0 | 0 | 7 | 13 | 8 | 2 |
| Investments | 20 | 105 | 167 | 174 | 157 | 158 | 169 | 172 | 163 | 67 | 80 | 72 |
| 65 | 107 | 68 | 69 | 55 | 45 | 47 | 50 | 55 | 83 | 81 | 97 | |
| Total Assets | 123 | 251 | 274 | 280 | 250 | 240 | 251 | 255 | 254 | 189 | 202 | 212 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | -28 | -3 | 8 | -16 | 2 | 4 | -0 | 0 | 11 | 18 | 12 | |
| 1 | 50 | 2 | 1 | 18 | 2 | -3 | 2 | 7 | -7 | -10 | -10 | |
| -8 | -20 | -1 | -5 | -7 | -6 | -0 | -3 | -7 | -3 | -6 | -2 | |
| Net Cash Flow | 1 | 2 | -2 | 4 | -5 | -1 | 1 | -1 | 0 | 1 | 3 | 0 |
| Free Cash Flow | 7 | -31 | -7 | 7 | -18 | 1 | 3 | -2 | -5 | 6 | 14 | -7 |
| CFO/OP | 123% | -653% | -39% | 166% | -305% | 223% | 180% | 62% | 65% | 209% | 153% | 82% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 52 | 62 | 59 | 93 | 106 | 160 | 171 | 166 | 116 | 87 | 86 |
| Inventory Days | 45 | 42 | 54 | 41 | 30 | 57 | 86 | 50 | 45 | 57 | 60 | 52 |
| Days Payable | 76 | 71 | 86 | 87 | 44 | 77 | 160 | 108 | 119 | 128 | 124 | 94 |
| Cash Conversion Cycle | 29 | 23 | 30 | 13 | 78 | 86 | 86 | 114 | 92 | 46 | 23 | 44 |
| Working Capital Days | -11 | 83 | 17 | 13 | 76 | 207 | 278 | 295 | 224 | 63 | 44 | 101 |
| ROCE % | 11% | 21% | 1% | 6% | 3% | 2% | 5% | 5% | 1% | 7% | 11% | 7% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover Ratio Ratio |
|
||||||||||
| Number of Manufacturing Plants Count |
|||||||||||
| R&D Spend (Consolidated) Rs. Lakhs |
|||||||||||
| Total Employees (Group level) Count |
|||||||||||
| Gross Current Assets (GCA) Days |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting
1d - Board approved FY26 audited results and recommended Rs.2 dividend per share, subject to AGM approval.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
2d - Annual Secretarial Compliance Report for FY2026; company reported full compliance.
-
Board Meeting Intimation for Intimation Of Meeting Of Board Of The Company Pursuant To Regulation 29 Of The SEBI (LODR) Regulations, 2015.
7 May - Board to meet on May 15, 2026 to approve FY26 audited results and consider dividend.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 May - Newspaper advertisements of notice regarding Second 100 Days campaign - Saksham Niveshak
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Apr - Newspaper Advertisements regarding Reminder Notice for transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
CCL manufactures specialty chemicals like high-performance coatings, automotive sealants,
metal treatment chemicals, engineering adhesives, vitamins & minerals, probiotics,
and prebiotic enzymes, and feed additives and nutrition products related to animal health, and industrial biotech products.